Cargando…
Origin of circulating free DNA in patients with lung cancer
Liquid biopsy has become widely applied in clinical medicine along with the progress in innovative technologies, such as next generation sequencing, but the origin of circulating tumor DNA (ctDNA) has not yet been precisely established. We reported bimodal peaks of long fragment circulating free DNA...
Autores principales: | Abe, Tomonori, Nakashima, Chiho, Sato, Akemi, Harada, Yohei, Sueoka, Eisaburo, Kimura, Shinya, Kawaguchi, Atsushi, Sueoka-Aragane, Naoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340299/ https://www.ncbi.nlm.nih.gov/pubmed/32634139 http://dx.doi.org/10.1371/journal.pone.0235611 |
Ejemplares similares
-
Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy
por: Sato, Akemi, et al.
Publicado: (2018) -
Automated DNA extraction using cellulose magnetic beads can improve EGFR point mutation detection with liquid biopsy by efficiently recovering short and long DNA fragments
por: Nakashima, Chiho, et al.
Publicado: (2018) -
Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test
por: Harada, Yohei, et al.
Publicado: (2022) -
Absence of copy number gain of EGFR: A possible predictive marker of long‐term response to afatinib
por: Nakamura, Tomomi, et al.
Publicado: (2022) -
Correlation between Plasma DNA and Tumor Status in an Animal Model
por: Sueoka-Aragane, Naoko, et al.
Publicado: (2014)